Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults

被引:3
作者
Aronow, Wilbert S. [1 ]
机构
[1] New York Med Coll, Westchester Med Ctr, Dept Med, Div Cardiol, Macy Pavil,Room 141, Valhalla, NY 10595 USA
关键词
Heart failure; Myocardial infarction; Beta blockers; Angiotensin-converting enzyme inhibitors; Nitrates; Aldosterone antagonists; Digoxin; Positive inotropic drugs; CONVERTING-ENZYME-INHIBITORS; CARDIAC-RESYNCHRONIZATION THERAPY; PRIOR MYOCARDIAL-INFARCTION; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; PERIPHERAL ARTERIAL-DISEASE; SERUM DIGOXIN CONCENTRATION; LIPID-LOWERING DRUGS; RANDOMIZED-TRIAL; BETA-BLOCKERS; CORONARY EVENTS;
D O I
10.1016/j.hfc.2017.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) with abnormal left ventricular (LV) ejection fraction should be identified and treated. Treat hypertension with diuretics, angiotensin-converting enzyme (ACE) inhibitors, and beta-blockers. Treat myocardial ischemia with nitrates and beta-blockers. Treat volume overload and HF with diuretics. Treat HF with ACE inhibitors and beta-blockers. Sacubitril/valsartan may be used instead of an ACE inhibitor or ARB in chronic symptomatic HF and abnormal LV ejection fraction. Add isosorbide dinitrate/hydralazine in African Americans with class II to IV HF treated with diuretics, ACE inhibitors, and beta-blockers. Exercise training is recommended. Indications for implantable cardioverter-defibrillator and cardiac resynchronization therapy are discussed.
引用
收藏
页码:467 / +
页数:19
相关论文
共 127 条
[1]  
Abraham WT, 2001, J AM COLL CARDIOL, V38, P612
[2]   Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction [J].
Ahmed, A ;
Aban, IB ;
Weaver, MT ;
Aronow, WS ;
Fleg, JL .
EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (04) :409-419
[3]   Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial [J].
Al-Khadra, AS ;
Salem, DN ;
Rand, WM ;
Udelson, JE ;
Smith, JJ ;
Konstam, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :419-425
[4]  
[Anonymous], 1990, Lancet, V336, P1
[5]  
[Anonymous], 1992, NEW ENGL J MED, V327, P685, DOI [10.1056/NEJM199209033271003.Erratumin, DOI 10.1056/NEJM199209033271003]
[6]  
ARONOW W S, 1991, Drugs and Aging, V1, P98, DOI 10.2165/00002512-199101020-00002
[7]  
Aronow W S, 2001, Am J Geriatr Cardiol, V10, P245, DOI 10.1111/j.1076-7460.2001.00803.x
[8]  
Aronow WS, 2009, MINERVA MED, V100, P3
[9]  
Aronow WS, 2011, J AM SOC HYPERTENS, V5, P259, DOI [10.1016/j.jash.2011.06.001, 10.1016/j.jacc.2011.01.008]
[10]   Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease [J].
Aronow, WS ;
Ahn, C .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (11) :1284-1286